The inclusion of plasma sPD-L1 and sPD-1 in a diagnostic panel, together with urinary PSMA, PCA3, and AR mRNA transcripts, has the potential to significantly improve PCa diagnostics. Here, AR is linked to posterior cortical atrophy.